Bob Pettigrew

Bob has more than 20 years experience in the development of emerging businesses having been a director and investor in a number of growth oriented companies over this period.

In 1986 he co-founded Generics which has grown rapidly to become one of the leading technology consulting and investment groups and was a key member of the team that took the company public in December 2000. He also was involved in developing Generics investment activities in early stage technology ventures and was a director of the group investment company Generics asset management. He retired from Generics at the end of 2002 to pursue independent investment activities. He is an investor director on the board of a number of technology companies including, Sphere Medical Devices, BioWisdom, Zinwave, Oxonica and Digital Health Care. He was also Chairman of Voxar Ltd and managed its $50m trade sale in Sept 2004. Additionally he is chairman of Genesis Ltd and is also a member of the advisory boards of Antenova, the Synergy Fund as well as being a non executive board member of 3 Venture Capital Trusts listed on the London stock exchange.